Aurobindo Pharma
AUROPHARMA.NSApprovedAurobindo Pharma Limited is a vertically integrated pharmaceutical company founded in 1986, headquartered in Hyderabad, India. The company has established itself as a major player in the global generics market with a diverse portfolio spanning antibiotics, ARVs, CVS, CNS, gastroenterology, and other therapeutic segments. With multiple manufacturing facilities across India, the US, and other countries, Aurobindo has built a robust supply chain and regulatory compliance framework serving both developed and emerging markets.
AUROPHARMA.NS · Stock Price
Historical price data
AI Company Overview
Aurobindo Pharma Limited is a vertically integrated pharmaceutical company founded in 1986, headquartered in Hyderabad, India. The company has established itself as a major player in the global generics market with a diverse portfolio spanning antibiotics, ARVs, CVS, CNS, gastroenterology, and other therapeutic segments. With multiple manufacturing facilities across India, the US, and other countries, Aurobindo has built a robust supply chain and regulatory compliance framework serving both developed and emerging markets.
Technology Platform
Vertically integrated pharmaceutical manufacturing platform specializing in generic drugs, APIs, and complex formulations with strong regulatory compliance capabilities across global markets.
Pipeline Snapshot
66 drugs in pipeline, 3 in Phase 3
| Drug | Indication | Stage |
|---|---|---|
| Test Product + Reference Product + Placebo | Bronchial Asthma | Phase 3 |
| Adapalene 0.1% Gel + Differin 0.1% Topical Gel | Acne Vulgaris | Phase 3 |
| Albuterol Sulfate HFA 0.09 mg (Reference) + Albuterol Sulfate HFA 0.18 mg (Refer... | Bronchial Asthma | Phase 3 |
| Amphotericin B Liposome + AmBisome (Amphotericin B) Liposome | Visceral Leishmaniasis | Phase 1 |
| Amlodipine - reference + Amlodipine ODT - test + Amlodipine ODT - test | Healthy Volunteers | Phase 1 |
Funding History
1FDA Approved Drugs
442Opportunities
Risk Factors
Competitive Landscape
Aurobindo competes in a highly competitive global generics market against companies like Teva, Dr. Reddy's, Sun Pharma, and Cipla. The company differentiates through vertical integration, broad therapeutic portfolio, and strong presence in both developed and emerging markets.
Company Info
Trading
Contact
Therapeutic Areas
Partners
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile